AbbVie stock slips after $1.3 billion R&D charge and Revolution Medicines rumor — what investors watch next
AbbVie Inc. shares dropped 1.8% on Friday, closing at $220.08. The decline followed the drugmaker’s decision to lower its 2025 earnings forecast and a…

















